A 5-YEAR PROSPECTIVE FOLLOW-UP OF 675 RHEUMATOID-ARTHRITIS (RA) PATIENTS TREATED WITH INTRAMUSCULAR GOLD (GST), PENICILLAMINE (PEN) OR SULFASALAZINE (SASP) IN A SINGLE-CENTER
Ha. Capell et al., A 5-YEAR PROSPECTIVE FOLLOW-UP OF 675 RHEUMATOID-ARTHRITIS (RA) PATIENTS TREATED WITH INTRAMUSCULAR GOLD (GST), PENICILLAMINE (PEN) OR SULFASALAZINE (SASP) IN A SINGLE-CENTER, Arthritis and rheumatism, 36(9), 1993, pp. 190000180-190000180